This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:
1532533-67-7
Purity:
98.69
Molecular Weight:
571.55
Alternative Names:
TGR-1202; RP5264
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Umbralisib (TGR-1202) is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 µM, respectively. Umbralisib exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib can be used for haematological malignancies reseach[1][2][3][4].
Storage Temperature:
-20°C, 3 years; 4°C, 2 years (Powder)